Background: Deoxyribonucleic acid (DNA) methylation is an epigenetic modification involved in gene expression regulation, usually via gene silencing, which contributes to the risks of many multifactorial diseases. The aim of the present study was to analyze the influence of resting oxygen consumption on global and gene DNA methylation as well as protein secretion of inflammatory markers in blood cells from obese subjects with sleep apnea-hypopnea syndrome (SAHS). Methods: A total of 44 obese participants with SAHS were categorized in 2 groups according to their resting oxygen consumption. DNA methylation levels were evaluated using a methylation-sensitive high resolution melting approach. Results: The analyzed interleukin 6 (IL6) gene cytosine phosphate guanine (CpG) islands showed a hypomethylation, while serum IL-6 was higher in the low compared to the high oxygen consumption group (p < 0.05). Moreover, an age-related loss of DNA methylation of tumor necrosis factor (B = -0.82, 95% CI -1.33 to -0.30) and long interspersed nucleotide element 1 (B = -0.46; 95% CI -0.87 to -0.04) gene CpGs were found. Finally, studied CpG methylation levels of serpin peptidase inhibitor, clade E member 1 (r = 0.43; p = 0.01), and IL6 (r = 0.41; p = 0.02) were positively associated with fat-free mass. Conclusions: These findings suggest a potential role of oxygen in the regulation of inflammatory genes. Oxygen consumption measurement at rest could be proposed as a clinical biomarker of metabolic health.

Keywords:
High resolution melting assay, Obesity, Metabolic syndrome, Inflammation, Aging
1.
Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al: Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766-781.
2.
Tuomilehto H, Seppa J, Uusitupa M: Obesity and obstructive sleep apnea - clinical significance of weight loss. Sleep Med Rev 2013;17:321-329.
3.
Tasali E, Van Cauter E: Sleep-disordered breathing and the current epidemic of obesity: consequence or contributing factor? Am J Respir Crit Care Med 2002;165:562-563.
4.
Carreau A, El Hafny-Rahbi B, Matejuk A, Grillon C, Kieda C: Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J Cell Mol Med 2011;15:1239-1253.
5.
Trayhurn P: Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev 2013;93:1-21.
6.
Bondia-Pons I, Ryan L, Martinez JA: Oxidative stress and inflammation interactions in human obesity. J Physiol Biochem 2012;68:701-711.
7.
Goossens GH, Bizzarri A, Venteclef N, Essers Y, Cleutjens JP, Konings E, et al: Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation. Circulation 2011;124:67-76.
8.
Hodson L, Humphreys SM, Karpe F, Frayn KN: Metabolic signatures of human adipose tissue hypoxia in obesity. Diabetes 2013;62:1417-1425.
9.
Wilms B, Ernst B, Thurnheer M, Weisser B, Schultes B: Correction factors for the calculation of metabolic equivalents (MET) in overweight to extremely obese subjects. Int J Obes (Lond) 2014;38:1383-1387.
10.
Lubrano C, Genovesi G, Specchia P, Costantini D, Mariani S, Petrangeli E, et al: Obesity and metabolic comorbidities: environmental diseases? Oxid Med Cell Longev 2013;2013:640673.
11.
Ruemmele FM, Garnier-Lengline H: Why are genetics important for nutrition? Lessons from epigenetic research. Ann Nutr Metab 2012;60:38-43.
12.
Milagro FI, Mansego ML, De Miguel C, Martinez JA: Dietary factors, epigenetic modifications and obesity outcomes: progresses and perspectives. Mol Aspects Med 2013;34:782-812.
13.
Arner P, Sinha I, Thorell A, Ryden M, Dahlman-Wright K, Dahlman I: The epigenetic signature of subcutaneous fat cells is linked to altered expression of genes implicated in lipid metabolism in obese women. Clin Epigenetics 2015;7:93.
14.
Campion J, Milagro FI, Goyenechea E, Martinez JA: TNF-alpha promoter methylation as a predictive biomarker for weight-loss response. Obesity (Silver Spring) 2009;17:1293-1297.
15.
Ozanne SE, Constancia M: Mechanisms of disease: the developmental origins of disease and the role of the epigenotype. Nat Clin Pract Endocrinol Metab 2007;3:539-546.
16.
Rodenhiser D, Mann M: Epigenetics and human disease: translating basic biology into clinical applications. CMAJ 2006;174:341-348.
17.
Heyn H, Esteller M: DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet 2012;13:679-692.
18.
Bakulski KM, Fallin MD: Epigenetic epidemiology: promises for public health research. Environ Mol Mutagen 2014;55:171-183.
19.
Mansego ML, Milagro FI, Zulet MA, Moreno-Aliaga MJ, Martinez JA: Differential DNA methylation in relation to age and health risks of obesity. Int J Mol Sci 2015;16:16816-16832.
20.
Gillberg L, Ling C: The potential use of DNA methylation biomarkers to identify risk and progression of type 2 diabetes. Front Endocrinol (Lausanne) 2015;6:43.
21.
Zhang FF, Santella RM, Wolff M, Kappil MA, Markowitz SB, Morabia A: White blood cell global methylation and IL-6 promoter methylation in association with diet and lifestyle risk factors in a cancer-free population. Epigenetics 2012;7:606-614.
22.
Carless MA, Kulkarni H, Kos MZ, Charlesworth J, Peralta JM, Goring HH, et al: Genetic effects on DNA methylation and its potential relevance for obesity in Mexican Americans. PLoS One 2013;8:e73950.
23.
Dick KJ, Nelson CP, Tsaprouni L, Sandling JK, Aissi D, Wahl S, et al: DNA methylation and body-mass index: a genome-wide analysis. Lancet 2014;383:1990-1998.
24.
Relton CL, Groom A, St Pourcain B, Sayers AE, Swan DC, Embleton ND, et al: DNA methylation patterns in cord blood DNA and body size in childhood. PLoS One 2012;7:e31821.
25.
Su S, Zhu H, Xu X, Wang X, Dong Y, Kapuku G, et al: DNA methylation of the LY86 gene is associated with obesity, insulin resistance, and inflammation. Twin Res Hum Genet 2014;17:183-191.
26.
Wang X, Zhu H, Snieder H, Su S, Munn D, Harshfield G, et al: Obesity related methylation changes in DNA of peripheral blood leukocytes. BMC Med 2010;8:87.
27.
Demerath EW, Guan W, Grove ML, Aslibekyan S, Mendelson M, Zhou YH, et al: Epigenome-wide association study (EWAS) of BMI, BMI change and waist circumference in African American adults identifies multiple replicated loci. Hum Mol Genet 2015;24:4464-4479.
28.
Aslibekyan S, Demerath EW, Mendelson M, Zhi D, Guan W, Liang L, et al: Epigenome-wide study identifies novel methylation loci associated with body mass index and waist circumference. Obesity (Silver Spring) 2015;23:1493-1501.
29.
Li E, Zhang Y: DNA methylation in mammals. Cold Spring Harb Perspect Biol 2014;6:a019133.
30.
Garcia-Lacarte M, Milagro FI, Zulet MA, Martinez JA, Mansego ML: LINE-1 methylation levels, a biomarker of weight loss in obese subjects, are influenced by dietary antioxidant capacity. Redox Rep 2016;21:67-74.
31.
Mansego ML, Milagro FI, Campion J, Martinez JA: Techniques of DNA methylation analysis with nutritional applications. J Nutrigenet Nutrigenomics 2013;6:83-96.
32.
Turcot V, Tchernof A, Deshaies Y, Perusse L, Belisle A, Marceau S, et al: LINE-1 methylation in visceral adipose tissue of severely obese individuals is associated with metabolic syndrome status and related phenotypes. Clin Epigenetics 2012;4:10.
33.
Perng W, Villamor E, Shroff MR, Nettleton JA, Pilsner JR, Liu Y, et al: Dietary intake, plasma homocysteine, and repetitive element DNA methylation in the Multi-Ethnic Study of Atherosclerosis (MESA). Nutr Metab Cardiovasc Dis 2014;24:614-622.
34.
Viollet S, Monot C, Cristofari G: L1 retrotransposition: the snap-velcro model and its consequences. Mob Genet Elements 2014;4:e28907.
35.
Steegenga WT, Boekschoten MV, Lute C, Hooiveld GJ, de Groot PJ, Morris TJ, et al: Genome-wide age-related changes in DNA methylation and gene expression in human PBMCs. Age (Dordr) 2014;36:9648.
36.
Zheng LD, Linarelli LE, Liu L, Wall SS, Greenawald MH, Seidel RW, et al: Insulin resistance is associated with epigenetic and genetic regulation of mitochondrial DNA in obese humans. Clin Epigenetics 2015;7:60.
37.
Lopez-Legarrea P, Mansego ML, Zulet MA, Martinez JA: SERPINE1, PAI-1 protein coding gene, methylation levels and epigenetic relationships with adiposity changes in obese subjects with metabolic syndrome features under dietary restriction. J Clin Biochem Nutr 2013;53:139-144.
38.
Cordero P, Campion J, Milagro FI, Goyenechea E, Steemburgo T, Javierre BM, et al: Leptin and TNF-alpha promoter methylation levels measured by MSP could predict the response to a low-calorie diet. J Physiol Biochem 2011;67:463-470.
39.
Na YK, Hong HS, Lee WK, Kim YH, Kim DS: Increased methylation of interleukin 6 gene is associated with obesity in Korean women. Mol Cells 2015;38:452-456.
40.
Stewart A, Marfell-Jones M, Olds T, de Ridder H: International Standards for Anthropometric Assessment. ISAK; Lower Hutt, New Zealand, 2011.
41.
Li LC, Dahiya R: MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002;18:1427-1431.
42.
Daily K, Patel VR, Rigor P, Xie X, Baldi P: MotifMap: integrative genome-wide maps of regulatory motif sites for model species. BMC Bioinformatics 2011;12:495.
43.
Wojdacz TK, Dobrovic A: Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res 2007;35:e41.
44.
Tse MY, Ashbury JE, Zwingerman N, King WD, Taylor SA, Pang SC: A refined, rapid and reproducible high resolution melt (HRM)-based method suitable for quantification of global LINE-1 repetitive element methylation. BMC Res Notes 2011;4:565.
45.
Jette M, Sidney K, Blumchen G: Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity. Clin Cardiol 1990;13:555-565.
46.
González-Muniesa P, Garcia-Gerique L, Quintero P, Arriaza S, Lopez-Pascual A, Martinez JA: Effects of hyperoxia on oxygen-related inflammation with a focus on obesity. Oxid Med Cell Longev 2015;2015:8957827.
47.
Semenza GL: Hypoxia-inducible factors in physiology and medicine. Cell 2012;148:399-408.
48.
Sindhu S, Thomas R, Shihab P, Sriraman D, Behbehani K, Ahmad R: Obesity is a positive modulator of IL-6R and IL-6 expression in the subcutaneous adipose tissue: significance for metabolic inflammation. PLoS One 2015;10:e0133494.
49.
Yamaguchi K, Nishimura T, Ishiba H, Seko Y, Okajima A, Fujii H, et al: Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice. Liver Int 2015;35:550-561.
50.
Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, et al: Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 2009;5:e1000602.
51.
Gowers IR, Walters K, Kiss-Toth E, Read RC, Duff GW, Wilson AG: Age-related loss of CpG methylation in the tumour necrosis factor promoter. Cytokine 2011;56:792-797.
52.
Pawelec G, Goldeck D, Derhovanessian E: Inflammation, ageing and chronic disease. Curr Opin Immunol 2014;29:23-28.
53.
Hermsdorff HH, Barbosa KB, Volp AC, Puchau B, Bressan J, Zulet MA, et al: Gender-specific relationships between plasma oxidized low-density lipoprotein cholesterol, total antioxidant capacity, and central adiposity indicators. Eur J Prev Cardiol 2014;21:884-891.
54.
Marin JM, Artal J, Martin T, Carrizo SJ, Andres M, Martin-Burriel I, et al: Epigenetics modifications and subclinical atherosclerosis in obstructive sleep apnea: the EPIOSA study. BMC Pulm Med 2014;14:114.
55.
Kheirandish-Gozal L, Khalyfa A, Gozal D, Bhattacharjee R, Wang Y: Endothelial dysfunction in children with obstructive sleep apnea is associated with epigenetic changes in the eNOS gene. Chest 2013;143:971-977.
56.
Kim J, Bhattacharjee R, Khalyfa A, Kheirandish-Gozal L, Capdevila OS, Wang Y, et al: DNA methylation in inflammatory genes among children with obstructive sleep apnea. Am J Respir Crit Care Med 2012;185:330-338.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.